The Anticancer Effects of Novel α-Bisabolol Derivatives Against Pancreatic Cancer
Yoshihiko Murata(University of Tsukuba), Masato Nagino(Nagoya University)
Cited by 35
Related Papers
<i><scp>ECT</scp>2</i> amplification and overexpression as a new prognostic biomarker for early‐stage lung adenocarcinoma
|Cancer Science|2014|30
MZB1 expression indicates poor prognosis in estrogen receptor‑positive breast cancer
|Oncology Letters|2020|29
Therapeutic potential of targeting protein for Xklp2 silencing for pancreatic cancer
|Cancer Medicine|2015|15